These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23707467)

  • 1. Low temperature extruded implants based on novel hydrophilic multiblock copolymer for long-term protein delivery.
    Stanković M; de Waard H; Steendam R; Hiemstra C; Zuidema J; Frijlink HW; Hinrichs WL
    Eur J Pharm Sci; 2013 Jul; 49(4):578-87. PubMed ID: 23707467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored protein release from biodegradable poly(ε-caprolactone-PEG)-b-poly(ε-caprolactone) multiblock-copolymer implants.
    Stanković M; Tomar J; Hiemstra C; Steendam R; Frijlink HW; Hinrichs WL
    Eur J Pharm Biopharm; 2014 Jul; 87(2):329-37. PubMed ID: 24602675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein release from water-swellable poly(D,L-lactide-PEG)-b-poly(ϵ-caprolactone) implants.
    Stanković M; Hiemstra C; de Waard H; Zuidema J; Steendam R; Frijlink HW; Hinrichs WL
    Int J Pharm; 2015 Mar; 480(1-2):73-83. PubMed ID: 25575472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic studies on the release of lysozyme from twin-screw extruded lipid implants.
    Sax G; Winter G
    J Control Release; 2012 Oct; 163(2):187-94. PubMed ID: 22964391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein.
    Tang Y; Singh J
    Int J Pharm; 2009 Jan; 365(1-2):34-43. PubMed ID: 18786623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osmotic pressure driven protein release from viscous liquid, hydrophobic polymers based on 5-ethylene ketal ε-caprolactone: potential and mechanism.
    Babasola IO; Zhang W; Amsden BG
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):765-72. PubMed ID: 23665446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
    Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A
    Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of proteins from degradable poly(ether-ester) multiblock copolymers.
    van Dijkhuizen-Radersma R; Métairie S; Roosma JR; de Groot K; Bezemer JM
    J Control Release; 2005 Jan; 101(1-3):175-86. PubMed ID: 15588903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
    Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior.
    Gong C; Shi S; Wu L; Gou M; Yin Q; Guo Q; Dong P; Zhang F; Luo F; Zhao X; Wei Y; Qian Z
    Acta Biomater; 2009 Nov; 5(9):3358-70. PubMed ID: 19470411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels.
    Hiemstra C; Zhong Z; Van Tomme SR; van Steenbergen MJ; Jacobs JJ; Otter WD; Hennink WE; Feijen J
    J Control Release; 2007 Jun; 119(3):320-7. PubMed ID: 17475360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled protein release from electrospun biodegradable fiber mesh composed of poly(epsilon-caprolactone) and poly(ethylene oxide).
    Kim TG; Lee DS; Park TG
    Int J Pharm; 2007 Jun; 338(1-2):276-83. PubMed ID: 17321084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable and thermoreversible hydrogels of poly(ethylene glycol)-poly(epsilon-caprolactone-co-glycolide)-poly(ethylene glycol) aqueous solutions.
    Jiang Z; Hao J; You Y; Liu Y; Wang Z; Deng X
    J Biomed Mater Res A; 2008 Oct; 87(1):45-51. PubMed ID: 18080306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY
    Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the thermo- and pH-responsive assembly of triblock copolymers based on poly(ethylene glycol) and functionalized poly(ε-caprolactone).
    Safaei Nikouei N; Lavasanifar A
    Acta Biomater; 2011 Oct; 7(10):3708-18. PubMed ID: 21672641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices.
    Dierickx L; Saerens L; Almeida A; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Aug; 81(3):683-9. PubMed ID: 22504402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z
    Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermosensitive β-cyclodextrin modified poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) micelles prolong the anti-inflammatory effect of indomethacin following local injection.
    Wei X; Lv X; Zhao Q; Qiu L
    Acta Biomater; 2013 Jun; 9(6):6953-63. PubMed ID: 23416577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.
    Stewart SA; Domínguez-Robles J; McIlorum VJ; Gonzalez Z; Utomo E; Mancuso E; Lamprou DA; Donnelly RF; Larrañeta E
    Mol Pharm; 2020 Sep; 17(9):3487-3500. PubMed ID: 32672976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.